Trial Profile
Dietary Fat, Lipoprotein and Lipopolysaccharide: Role in Insulin Resistance
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Inflammation; Insulin resistance
- Focus Pharmacodynamics; Proof of concept
- 06 Aug 2019 Status changed from recruiting to completed.
- 13 Mar 2019 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 13 Mar 2019 Planned primary completion date changed from 31 May 2018 to 31 May 2019.